In the last trading session, 2.25 million Revelation Biosciences Inc (NASDAQ:REVB) shares changed hands as the company’s beta touched 0.10. With the company’s per share price at $3.00 changed hands at -$0.4 or -11.76% during last session, the market valuation stood at $2.72M. REVB’s last price was a discount, traded about -1926.67% off its 52-week high of $60.80. The share price had its 52-week low at $3.19, which suggests the last value was -6.33% down since then. When we look at Revelation Biosciences Inc’s average trading volume, we note the 10-day average is 0.26 million shares, with the 3-month average coming to 219.42K.
Analysts gave the Revelation Biosciences Inc (REVB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended REVB as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Revelation Biosciences Inc’s EPS for the current quarter is expected to be -6.88.
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Instantly REVB was in red as seen at the end of in last trading. With action -10.71%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -59.33%, with the 5-day performance at -10.71% in the red. However, in the 30-day time frame, Revelation Biosciences Inc (NASDAQ:REVB) is -27.88% down. Looking at the short shares, we see there were 61699.0 shares sold at short interest cover period of 0.37 days.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for Revelation Biosciences Inc earnings to increase by 75.25%, but the outlook for the next 5-year period is at 68.43% per year.
REVB Dividends
Revelation Biosciences Inc is expected to release its next quarterly earnings report on 2025-Mar-05.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.06% of Revelation Biosciences Inc shares while 6.81% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.81%.
